Open AccessDoes social environment affect arthritis patients' ability to remain on methotrexate treatment?
Author(s) -
BAYRAKTAR A.,
HUDSON S.,
WATSON A.,
FRASER S.,
HUNTER J.
Publication year - 2001
Publication title -
international journal of pharmacy practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.42
H-Index - 37
eISSN - 2042-7174
pISSN - 0961-7671
DOI - 10.1111/j.2042-7174.2001.tb01135.x
Subject(s) - medicine , affect (linguistics) , methotrexate , arthritis , communication , sociology
Focal points □ Drug toxicity is still a major limiting factor for methotrexate treatment continuation □ Treatment discontinuation within 12 months of start of methotrexate in this UK cohort was 20% (SE 2%) □ The monitoring of tolerance to methotrexate has implications for the dispensing of the drug in primary care □ Although social circumstances may have a role in arthritis patients' psychosocial health status, continuation rates of methotrexate in “affluent” and “deprived” patients were similar at the end of the first and second years of treatment □ The reasons for lower socio‐economic groups being discontinued on lower methotrexate doses warrant further study